1. Home
  2. THRD vs VREX Comparison

THRD vs VREX Comparison

Compare THRD & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • VREX
  • Stock Information
  • Founded
  • THRD 2019
  • VREX 2016
  • Country
  • THRD United States
  • VREX United States
  • Employees
  • THRD N/A
  • VREX N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • THRD Health Care
  • VREX Technology
  • Exchange
  • THRD Nasdaq
  • VREX Nasdaq
  • Market Cap
  • THRD 513.2M
  • VREX 582.3M
  • IPO Year
  • THRD 2022
  • VREX N/A
  • Fundamental
  • Price
  • THRD $10.84
  • VREX $14.16
  • Analyst Decision
  • THRD Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • THRD 3
  • VREX 1
  • Target Price
  • THRD $20.33
  • VREX $21.00
  • AVG Volume (30 Days)
  • THRD 259.3K
  • VREX 684.4K
  • Earning Date
  • THRD 11-07-2024
  • VREX 02-04-2025
  • Dividend Yield
  • THRD N/A
  • VREX N/A
  • EPS Growth
  • THRD N/A
  • VREX N/A
  • EPS
  • THRD N/A
  • VREX N/A
  • Revenue
  • THRD N/A
  • VREX $811,000,000.00
  • Revenue This Year
  • THRD N/A
  • VREX $3.50
  • Revenue Next Year
  • THRD N/A
  • VREX $3.37
  • P/E Ratio
  • THRD N/A
  • VREX N/A
  • Revenue Growth
  • THRD N/A
  • VREX N/A
  • 52 Week Low
  • THRD $8.08
  • VREX $10.19
  • 52 Week High
  • THRD $16.94
  • VREX $21.06
  • Technical
  • Relative Strength Index (RSI)
  • THRD 40.49
  • VREX 36.68
  • Support Level
  • THRD $10.53
  • VREX $14.05
  • Resistance Level
  • THRD $11.84
  • VREX $15.42
  • Average True Range (ATR)
  • THRD 0.86
  • VREX 0.56
  • MACD
  • THRD -0.07
  • VREX -0.30
  • Stochastic Oscillator
  • THRD 17.60
  • VREX 4.33

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.

Share on Social Networks: